RankAlpha logo
Back to Rankings

SBC

SBC Medical GroupA
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart
Current thesis
Q2 revenue rose 13% year over year to about $49 million and adjusted EBITDA rose 32% to about $20 million; sustained fee increases and network growth could extend the recovery. [#SEC-8K-2026-08-13]
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.4.
What can break
First-half adjusted EBITDA remained below the prior-year period despite Q2 improvement. Company Q2 release
Momentum
96
Value
72
Sentiment
57
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $6.10 · Bull $8.50 · Bear $3.40Analysis 2026-10-24; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-24 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-28

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions

Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $8.75
Why
Momentum96 · Δ7d -
Value72 · Δ7d +0.4
Sentiment57 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Value remains the lead driver in the composite, 7D delta +0.4.

Contradictions & invalidation

  • • First-half adjusted EBITDA remained below the prior-year period despite Q2 improvement. Company Q2 release
  • • Related-party receivables and dependence on affiliated medical corporations warrant collection and concentration monitoring. Company Q2 release
  • • First-half revenue grew only 2% and adjusted EBITDA declined 4% year over year despite the stronger Q2.

Catalyst clock

2026-10-22

DNA-methylation test development announced

Lead driver: Value · See fundamentals
Momentum
96
8% active weight
Current posture
7d trendFlat
Δ7d
-
Δ21d
-
Value
72
47% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
+0.1
Sentiment
57
45% active weight
Current posture
7d trendImproving
Δ7d
-
Δ21d
-
Why this grade

Composite grade A. Momentum 96.5 / Value 71.6 / Sentiment 57.1

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-24. Scenario method

B+
Bull case
25%
Probability
Target price
$8.50
Analysis reference price unavailable
Analysis 2026-10-24 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$6.10
Analysis reference price unavailable
Analysis 2026-10-24 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$3.40
Analysis reference price unavailable
Analysis 2026-10-24 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$535.83M
Beta
1.13
Shares Out
102.85M
P/E (TTM)
10.7
P/S (TTM)
2.59
P/FCF (TTM)
26.88
Rev YoY
+13.4%
EPS YoY
+337.8%
Gross Margin
+71.0%
Op Margin
+37.3%
Net Debt
-$112.46M
Current Ratio
3.31
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data